Di Dai

675 total citations
45 papers, 513 citations indexed

About

Di Dai is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Di Dai has authored 45 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Virology, 15 papers in Infectious Diseases and 12 papers in Immunology. Recurrent topics in Di Dai's work include HIV Research and Treatment (22 papers), HIV/AIDS drug development and treatment (12 papers) and Immune Cell Function and Interaction (10 papers). Di Dai is often cited by papers focused on HIV Research and Treatment (22 papers), HIV/AIDS drug development and treatment (12 papers) and Immune Cell Function and Interaction (10 papers). Di Dai collaborates with scholars based in China, United States and Japan. Di Dai's co-authors include Hong Shang, Xiaoxu Han, Fangjie Chen, Naren two ya Bao, Jing Liu, Zining Zhang, Yongjun Jiang, Wenqing Geng, Bin Zhao and Zhenxing Chu and has published in prestigious journals such as Nature Communications, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Di Dai

41 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Di Dai China 14 187 184 124 106 78 45 513
Zhong He United States 11 214 1.1× 223 1.2× 210 1.7× 128 1.2× 403 5.2× 20 825
Víctor Casanova Spain 12 55 0.3× 151 0.8× 121 1.0× 209 2.0× 120 1.5× 15 501
John Bial United States 9 25 0.1× 39 0.2× 127 1.0× 116 1.1× 79 1.0× 11 603
S.J. Bell Australia 11 26 0.1× 58 0.3× 161 1.3× 101 1.0× 53 0.7× 18 451
Veerle Van Eygen Belgium 18 671 3.6× 702 3.8× 230 1.9× 199 1.9× 37 0.5× 36 936
Sorin Claudiu Man Romania 11 19 0.1× 39 0.2× 63 0.5× 176 1.7× 29 0.4× 47 419
Susanna E. Schlegel‐Haueter Switzerland 9 23 0.1× 122 0.7× 111 0.9× 135 1.3× 297 3.8× 16 669
Nabanita Biswas United States 9 71 0.4× 84 0.5× 62 0.5× 87 0.8× 81 1.0× 9 281
Akiko Kawabata Japan 12 23 0.1× 127 0.7× 157 1.3× 401 3.8× 64 0.8× 36 685

Countries citing papers authored by Di Dai

Since Specialization
Citations

This map shows the geographic impact of Di Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di Dai more than expected).

Fields of papers citing papers by Di Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Di Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di Dai. The network helps show where Di Dai may publish in the future.

Co-authorship network of co-authors of Di Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Di Dai. A scholar is included among the top collaborators of Di Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Di Dai. Di Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Zhihao, Di Dai, Xiaoding Ma, et al.. (2025). Engineered bacteria for near-infrared light-inducible expression of cancer therapeutics. Nature Cancer. 6(4). 612–628. 16 indexed citations
2.
Li, Wei, et al.. (2025). Virus-mimic nanoparticles exhibiting enhanced permeability and microenvironment response for cancer therapy. Colloids and Surfaces B Biointerfaces. 254. 114818–114818.
3.
Wu, Xin, Meiyan Wang, Di Dai, et al.. (2024). AAV-delivered muscone-induced transgene system for treating chronic diseases in mice via inhalation. Nature Communications. 15(1). 1122–1122. 8 indexed citations
4.
5.
Wang, Xinyi, Liping Kang, Deqiang Kong, et al.. (2023). A programmable protease-based protein secretion platform for therapeutic applications. Nature Chemical Biology. 20(4). 432–442. 17 indexed citations
6.
Dai, Di, et al.. (2022). Clinical effect of micturition interruption exercise on urinary incontinence after radical prostatectomy. Supportive Care in Cancer. 30(4). 3241–3247. 2 indexed citations
7.
Li, Hao, Jingwei Liu, Di Dai, et al.. (2020). Pan‐cancer analysis of alternative splicing regulator heterogeneous nuclear ribonucleoproteins (hnRNPs) family and their prognostic potential. Journal of Cellular and Molecular Medicine. 24(19). 11111–11119. 48 indexed citations
8.
Bao, Naren two ya, Fangjie Chen, & Di Dai. (2020). The Regulation of Host Intestinal Microbiota by Polyphenols in the Development and Prevention of Chronic Kidney Disease. Frontiers in Immunology. 10. 2981–2981. 35 indexed citations
9.
10.
11.
Zhao, Bin, Xiaoxu Han, Di Dai, et al.. (2011). New Trends of Primary Drug Resistance Among HIV Type 1-Infected Men Who Have Sex with Men in Liaoning Province, China. AIDS Research and Human Retroviruses. 27(10). 1047–1053. 43 indexed citations
12.
Zhang, Xiaoli, Xiaoxu Han, Di Dai, et al.. (2010). Association of variations of NAb 2F5 and 4E10 epitopes and disease progression in Chinese antiretroviral treatment-naïve patients infected with HIV-1 clade B'.. PubMed. 123(23). 3406–11. 1 indexed citations
13.
Geng, Wenqing, Yongjun Jiang, Xiaoxu Han, et al.. (2010). The Associations of hA3G and hA3B mRNA Levels With HIV Disease Progression Among HIV-Infected Individuals of China. JAIDS Journal of Acquired Immune Deficiency Syndromes. 53(Supplement 1). S4–S9. 7 indexed citations
14.
Shang, Hong, Ping Zhong, Jing Liu, et al.. (2010). High Prevalence and Genetic Diversity of HCV among HIV-1 Infected People from Various High-Risk Groups in China. PLoS ONE. 5(5). e10631–e10631. 30 indexed citations
15.
Han, Xiaoxu, Di Dai, Bin Zhao, et al.. (2010). Genetic and Epidemiologic Characterization of HIV-1 Infection In Liaoning Province, China. JAIDS Journal of Acquired Immune Deficiency Syndromes. 53(Supplement 1). S27–S33. 32 indexed citations
16.
Han, Xiaoxu, et al.. (2008). Cohort study of highly active antiretroviral therapy and drug resistant mutation in Henan Province,China. Zhonghua jianyan yixue zazhi. 31(10). 1101–1105. 3 indexed citations
17.
Zhang, Min, Xiaoxu Han, Wei-guo Cui, et al.. (2008). The Impacts of Current Antiretroviral Therapy Regimens on Chinese AIDS Patients and Their Implications for HIV-1 Drug Resistance Mutation. Japanese Journal of Infectious Diseases. 61(5). 361–365. 13 indexed citations
18.
Han, Xiaoxu, Min Zhang, Di Dai, et al.. (2007). Genotypic Resistance Mutations to Antiretroviral Drugs in Treatment-Naive HIV/AIDS Patients Living in Liaoning Province, China: Baseline Prevalence And Subtype-Specific Difference. AIDS Research and Human Retroviruses. 23(3). 357–364. 29 indexed citations
19.
Ye, Xiaohui, Zining Zhang, Yongjun Jiang, et al.. (2006). Expression of Human CD226 on T Cells and Natural Killer Cells and of Soluble CD226 in Plasma of HIV-1-Infected Chinese Patients. Viral Immunology. 19(3). 576–581. 8 indexed citations
20.
Zhang, Zining, Hong Shang, Yongjun Jiang, et al.. (2005). Coreceptor exprssion and activation of T lymphocytes induced by highly active anti--retroviral therapy. 25(4). 343–346.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhong He Breakdown of academic impact, for papers by Víctor Casanova Breakdown of academic impact, for papers by John Bial Breakdown of academic impact, for papers by S.J. Bell Breakdown of academic impact, for papers by Veerle Van Eygen Breakdown of academic impact, for papers by Sorin Claudiu Man Breakdown of academic impact, for papers by Susanna E. Schlegel‐Haueter Breakdown of academic impact, for papers by Nabanita Biswas Breakdown of academic impact, for papers by Akiko Kawabata
Rankless by CCL
2026